(1)
Schoedel, PhD, K. A.; Rolleri, PharmD, R. L.; Faulknor, MD, CCFP, J. Y.; Pixton, MS, G. C.; Chen, PhD, N.; Bass, PharmD, A.; Sommerville, MD, K. W.; Sellers, MD, PhD, FRCPC, FACP, E. Assessing Subjective and Physiologic Effects Following Intranasal Administration of a New Formulation of Immediate Release Oxycodone HCl (Oxectaâ„¢) Tablets in Nondependent Recreational Opioid Users. J of Opioid Management 2012, 8, 315-327.